Association of Systemic Inflammation and Low Performance Status with Reduced Survival Outcome in Older Adults with Cancer.
Guo-Tian Ruan,Hai-Lun Xie,He-Yang Zhang,Qi Zhang,Li Deng,Zi-Wen Wang,Xi Zhang,Yi-Zhong Ge,Chun-Lei Hu,Meng Tang,Meng-Meng Song,Xiao-Wei Zhang,Tong Liu,Xiang-Rui Li,Kang-Ping Zhang,Ming Yang,Yi-Zhen Gong,Yong-Bing Chen,Kai-Ying Yu,Ming-Hua Cong,Lei Pan,Wei-Zhong Tang,Kun-Hua Wang,Han-Ping Shi
DOI: https://doi.org/10.1016/j.clnu.2022.08.025
IF: 7.643
2022-01-01
Clinical Nutrition
Abstract:Background: Inflammation is involved in the progression and prognosis of cancer because it can affect the physical status and prognosis of patients. Among numerous systemic inflammatory markers, the optimal prognostic indicator of older adults with cancer is still unclear. We aimed to identify an ideal inflammatory immune marker in older adults with cancer and assess the survival outcome combined with eastern cooperative oncology group performance status (ECOG PS).Methods: We included 1767 older adults with cancer (66.2% males, 70.97 +/- 5.49 years old) from a prospective cohort study. Fifteen systemic inflammatory biomarkers were compared to identify the optimal biomarker using prognostic area under the curve (AUC) and concordance index (C-index) analysis. The prognostic value of the clinical parameters was elucidated by performing uni-and multi-variate analyses.Results: The AUC, C-index, and the subgroup survival analysis of ECOG PS groups showed that the lymphocyte-C reactive protein ratio (LCR) and C-reactive protein/albumin ratio (CAR) were more accu-rate in reflecting patient prognosis than the other 13 inflammatory markers. Compared with patients in the high LCR group, those in the low LCR group had worse survival (hazard ratio (HR) 1.64, 95% confi-dence interval (95%CI) 1.42-1.91, p < 0.001). Compared with patients in the low CAR group, those in the high CAR group had worse survival (HR 1.65, 95% CI 1.43-1.91, p < 0.001). Older adults with cancer with an ECOG PS score of 2 or 3-4 and a high inflammation (low LCR, 13.3 months and 9.2 months, respectively; or high CAR, 9.6 months and 9.6 months, respectively) had shorter median survival time compared to those with an ECOG PS score of 0/1 and a low inflammation (high LCR, 77.4 months; or low CAR, 77.0 months).Conclusion: LCR and CAR might be the better predictive immune inflammatory factors for OS, which improved the survival prediction of different ECOG PS groups in older adults with cancer. High ECOG PS (>= 2) and high inflammation increased the risk of death in older adults with cancer.(c) 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.